The impact of dry weight calculation by measuring serum sodium pre- dialysis on some of hemodialysis complications
Not Applicable
- Conditions
- Renal failure.Chronic kidney disease, stage 5
- Registration Number
- IRCT2015042318649N2
- Lead Sponsor
- Golestan University of Medical Sciences, Deputy of research and technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
history of dialysis more than one year; Age of 18-65 years; be able to communicate verbally; lack of syndrome of inappropriate antidiuretic hormone secretion and diabetes insipidus; lack of human immunodeficiency virus infection; lack of mechanical ventilation; do not have heart and liver failure; lack of an overactive adrenal gland; do not use serotonin inhibitor drugs; do not use anti-spasmodic and anti-hypertensive drugs four hours before of dialysis.
Exclusion criteria: The patient's unwillingness to continue for cooperating during the study; disruption of blood flow through the fistula.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood pressure disorders. Timepoint: At one hours interval during dialysis. Method of measurement: Blood pressure is measured using a sphygmomanometer.;Muscle cramps. Timepoint: At one hours interval during dialysis. Method of measurement: Using check list.;Nausea and vomiting. Timepoint: At one hours interval during dialysis. Method of measurement: Using check list.;Fatigue. Timepoint: At the end of dialysis. Method of measurement: Using Visual scale.
- Secondary Outcome Measures
Name Time Method